BRIEF-Oxigene receives U.S. orphan drug designation for CA4P to treat glioma
June 10, 2016 at 08:47 AM EDT
* Oxigene receives U.S. orphan drug designation for CA4P to treat glioma Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)